Jazz Pharmaceuticals Financials
| J7Z Stock | EUR 116.85 1.15 0.97% |
Jazz |
Jazz Pharmaceuticals Stock Summary
Jazz Pharmaceuticals competes with Novo Nordisk, CSL, CSL, Mercedes Benz, and Vertex Pharmaceuticals. Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. Jazz Pharmaceuticals plc has licensing and collaboration agreements with ImmunoGen, Inc. Codiak BioSciences, Inc. Pfenex, Inc. and XL-protein GmbH. JAZZ PHARMACEUT operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1460 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | IE00B4Q5ZN47 |
| Business Address | Waterloo Exchange, Dublin, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.jazzpharma.com |
| Phone | 353 1 634 7800 |
| Currency | EUR - Euro |
You should never invest in Jazz Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Jazz Stock, because this is throwing your money away. Analyzing the key information contained in Jazz Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Jazz Pharmaceuticals Key Financial Ratios
There are many critical financial ratios that Jazz Pharmaceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Jazz Pharmaceuticals plc reports annually and quarterly.| Return On Equity | -0.0056 | |||
| Return On Asset | 0.053 | |||
| Target Price | 208.5 | |||
| Beta | 0.71 | |||
| Z Score | 0.6 |
Jazz Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Jazz Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Jazz Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Jazz Pharmaceuticals competition to find correlations between indicators driving Jazz Pharmaceuticals's intrinsic value. More Info.Jazz Pharmaceuticals plc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Jazz Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Jazz Pharmaceuticals plc Systematic Risk
Jazz Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Jazz Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Jazz Pharmaceuticals plc correlated with the market. If Beta is less than 0 Jazz Pharmaceuticals generally moves in the opposite direction as compared to the market. If Jazz Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Jazz Pharmaceuticals plc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Jazz Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Jazz Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Jazz Pharmaceuticals December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Jazz Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Jazz Pharmaceuticals plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Jazz Pharmaceuticals plc based on widely used predictive technical indicators. In general, we focus on analyzing Jazz Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Jazz Pharmaceuticals's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.63 | |||
| Information Ratio | 0.1228 | |||
| Maximum Drawdown | 10.5 | |||
| Value At Risk | (2.65) | |||
| Potential Upside | 4.58 |
Complementary Tools for Jazz Stock analysis
When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |